Investors & Media Investor Relations Overview Press Releases Scientific Publications & Presentations Corporate Deck Events & Presentations Press Kit Corporate Governance Financial Info Stock Info Analyst Coverage Investor Resources Stock Information Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases Aug 04, 2022 Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress Read More Events & Presentations Aug 4, 2022 8:00 AM EDT Intellia Therapeutics Second Quarter 2022 Earnings Conference Call US dial-in: 1-833-316-0545 International dial-in: 1-412-317-5726 All participants should ask to be connected to the Intellia Therapeutics conference call. Add to Outlook Add to Google Calendar Click Here for Webcast Contact IR
Stock Information Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases Aug 04, 2022 Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress Read More Events & Presentations Aug 4, 2022 8:00 AM EDT Intellia Therapeutics Second Quarter 2022 Earnings Conference Call US dial-in: 1-833-316-0545 International dial-in: 1-412-317-5726 All participants should ask to be connected to the Intellia Therapeutics conference call. Add to Outlook Add to Google Calendar Click Here for Webcast
Aug 04, 2022 Intellia Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress Read More
Aug 4, 2022 8:00 AM EDT Intellia Therapeutics Second Quarter 2022 Earnings Conference Call US dial-in: 1-833-316-0545 International dial-in: 1-412-317-5726 All participants should ask to be connected to the Intellia Therapeutics conference call. Add to Outlook Add to Google Calendar Click Here for Webcast